Global Neuroendocrine Tumor Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Neuroendocrine Tumor Drug

• 1.1 Definition of Neuroendocrine Tumor Drug
• 1.2 Neuroendocrine Tumor Drug Segment by Type
  • 1.2.1 Global Neuroendocrine Tumor Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 mTOR protein inhibitors
  • 1.2.3 Tyrosine kinase 3 inhibitors
  • 1.2.4 Somatostatin receptor antagonists
  • 1.2.5 Growth hormone releasing factor antagonists
  • 1.2.6 Somatostatin receptor agonists
  • 1.2.7 Others
• 1.3 Neuroendocrine Tumor Drug Segment by Applications
  • 1.3.1 Global Neuroendocrine Tumor Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Neuroendocrine Tumor Drug Overall Market
  • 1.4.1 Global Neuroendocrine Tumor Drug Revenue (2014-2025)
  • 1.4.2 Global Neuroendocrine Tumor Drug Production (2014-2025)
  • 1.4.3 North America Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.5 China Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Neuroendocrine Tumor Drug Status and Prospect (2014-2025)
  • 1.4.8 India Neuroendocrine Tumor Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Tumor Drug
• 2.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug
• 2.4 Industry Chain Structure of Neuroendocrine Tumor Drug

3 Development and Manufacturing Plants Analysis of Neuroendocrine Tumor Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Neuroendocrine Tumor Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Neuroendocrine Tumor Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Neuroendocrine Tumor Drug Production and Capacity Analysis
• 4.2 Neuroendocrine Tumor Drug Revenue Analysis
• 4.3 Neuroendocrine Tumor Drug Price Analysis
• 4.4 Market Concentration Degree

5 Neuroendocrine Tumor Drug Regional Market Analysis

• 5.1 Neuroendocrine Tumor Drug Production by Regions
  • 5.1.1 Global Neuroendocrine Tumor Drug Production by Regions
  • 5.1.2 Global Neuroendocrine Tumor Drug Revenue by Regions
• 5.2 Neuroendocrine Tumor Drug Consumption by Regions
• 5.3 North America Neuroendocrine Tumor Drug Market Analysis
  • 5.3.1 North America Neuroendocrine Tumor Drug Production
  • 5.3.2 North America Neuroendocrine Tumor Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Neuroendocrine Tumor Drug Import and Export
• 5.4 Europe Neuroendocrine Tumor Drug Market Analysis
  • 5.4.1 Europe Neuroendocrine Tumor Drug Production
  • 5.4.2 Europe Neuroendocrine Tumor Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Neuroendocrine Tumor Drug Import and Export
• 5.5 China Neuroendocrine Tumor Drug Market Analysis
  • 5.5.1 China Neuroendocrine Tumor Drug Production
  • 5.5.2 China Neuroendocrine Tumor Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Neuroendocrine Tumor Drug Import and Export
• 5.6 Japan Neuroendocrine Tumor Drug Market Analysis
  • 5.6.1 Japan Neuroendocrine Tumor Drug Production
  • 5.6.2 Japan Neuroendocrine Tumor Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Neuroendocrine Tumor Drug Import and Export
• 5.7 Southeast Asia Neuroendocrine Tumor Drug Market Analysis
  • 5.7.1 Southeast Asia Neuroendocrine Tumor Drug Production
  • 5.7.2 Southeast Asia Neuroendocrine Tumor Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Neuroendocrine Tumor Drug Import and Export
• 5.8 India Neuroendocrine Tumor Drug Market Analysis
  • 5.8.1 India Neuroendocrine Tumor Drug Production
  • 5.8.2 India Neuroendocrine Tumor Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Neuroendocrine Tumor Drug Import and Export

6 Neuroendocrine Tumor Drug Segment Market Analysis (by Type)

• 6.1 Global Neuroendocrine Tumor Drug Production by Type
• 6.2 Global Neuroendocrine Tumor Drug Revenue by Type
• 6.3 Neuroendocrine Tumor Drug Price by Type

7 Neuroendocrine Tumor Drug Segment Market Analysis (by Application)

• 7.1 Global Neuroendocrine Tumor Drug Consumption by Application
• 7.2 Global Neuroendocrine Tumor Drug Consumption Market Share by Application (2014-2019)

8 Neuroendocrine Tumor Drug Major Manufacturers Analysis

• 8.1 Eisai
  • 8.1.1 Eisai Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.1.2 Eisai Product Introduction, Application and Specification
  • 8.1.3 Eisai Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Exelixis, Inc.
  • 8.2.1 Exelixis, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.2.2 Exelixis, Inc. Product Introduction, Application and Specification
  • 8.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Foresee Pharmaceuticals, LLC
  • 8.3.1 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.3.2 Foresee Pharmaceuticals, LLC Product Introduction, Application and Specification
  • 8.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Hutchison MediPharma Limited
  • 8.4.1 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.4.2 Hutchison MediPharma Limited Product Introduction, Application and Specification
  • 8.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Intezyne, Inc
  • 8.5.1 Intezyne, Inc Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.5.2 Intezyne, Inc Product Introduction, Application and Specification
  • 8.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 INVENT Pharmaceuticals, Inc.
  • 8.6.1 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.6.2 INVENT Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Ipsen S.A.
  • 8.7.1 Ipsen S.A. Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.7.2 Ipsen S.A. Product Introduction, Application and Specification
  • 8.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Jiangsu Hengrui Medicine Co., Ltd.
  • 8.8.1 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.8.2 Jiangsu Hengrui Medicine Co., Ltd. Product Introduction, Application and Specification
  • 8.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Karyopharm Therapeutics, Inc.
  • 8.9.1 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.9.2 Karyopharm Therapeutics, Inc. Product Introduction, Application and Specification
  • 8.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Lexicon Pharmaceuticals, Inc.
  • 8.10.1 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Sites and Area Served
  • 8.10.2 Lexicon Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Midatech Pharma Plc .
• 8.12 Millennium Pharmaceuticals, Inc.
• 8.13 MolMed S.p.A.
• 8.14 Northwest Biotherapeutics, Inc.
• 8.15 Novartis AG
• 8.16 OctreoPharm Sciences GmbH
• 8.17 OXiGENE, Inc.

9 Development Trend of Analysis of Neuroendocrine Tumor Drug Market

• 9.1 Global Neuroendocrine Tumor Drug Market Trend Analysis
  • 9.1.1 Global Neuroendocrine Tumor Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Neuroendocrine Tumor Drug Regional Market Trend
  • 9.2.1 North America Neuroendocrine Tumor Drug Forecast 2019-2025
  • 9.2.2 Europe Neuroendocrine Tumor Drug Forecast 2019-2025
  • 9.2.3 China Neuroendocrine Tumor Drug Forecast 2019-2025
  • 9.2.4 Japan Neuroendocrine Tumor Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Neuroendocrine Tumor Drug Forecast 2019-2025
  • 9.2.6 India Neuroendocrine Tumor Drug Forecast 2019-2025
• 9.3 Neuroendocrine Tumor Drug Market Trend (Product Type)
• 9.4 Neuroendocrine Tumor Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Neuroendocrine Tumor Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List